Social Media Newsroom
About
Vivacelle Bio, Inc. is a clinical stage life science company focused on a new paradigm of nitric oxide redistribution that utilizes biophysical properties of phospholipid nanoparticles. The Company’s first product, VBI-S is designed to treat septic shock caused by COVID-19, other viruses, bacteria, parasites or fungi.
Connect
Press Contact
- Name
- Harven DeShield
- Phone
- 716-830-8932
- Contact Us
- Website
- https://vivacellebio.com
Press Releases
Vivacelle Bio Announces Compassionate Use for COVID-19 Patients with Its Sepsis Treatment, VBI-S
×
Volume Pricing
We know many of you need to send dozens or even hundreds of press releases each month for your clients or your company, and we allow multiple newsrooms so you can manage multiple clients. We also do offer volume pricing for clients who can commit to a specific number of press releases each month.
NOTE: This is for our core distribution service and NOT the US National distribution plan.
The core distribution service goes to Google News, Twitter, DigitalJournal.com and ~150+ news and TV websites (See sites).
If you are looking to send 10 or more Releases per month, please fill out the form below to contact us
